Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical Trials Insight: 700015653

Trial Profile

Clinical Trials Insight: 700015653

Phase of Trial: Phase II

Latest Information Update: 24 Jul 2009

At a glance

  • Drugs Adecatumumab (Primary)
  • Indications Advanced breast cancer
  • Focus Pharmacogenomic; Therapeutic Use
  • Most Recent Events

    • 24 Jul 2009 Primary endpoint 'clinical-benfit-rate (complete clinical response + partial clinical response + stable disease)' has not been met according to results published in the Annals of Oncology.
    • 05 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top